Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 206,152 | 4,960 | 125,298 | 22,020 | 11,593 |
| Marketable Securities | 161,985 | 112,904 | 79,194 | 0 | 35,928 |
| Receivables | 5,559 | 6,298 | 2,489 | 1,624 | 577 |
| TOTAL | $378,182 | $128,568 | $209,946 | $25,629 | $49,688 |
| Non-Current Assets | |||||
| PPE Net | 12,935 | 9,633 | 10,934 | 13,997 | 18,690 |
| Investments And Advances | 0 | 15,609 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,994 | 2,560 | 2,259 | 1,143 | 899 |
| TOTAL | $15,929 | $27,802 | $13,193 | $15,140 | $19,589 |
| Total Assets | $394,111 | $156,370 | $223,139 | $40,769 | $69,277 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,000 | 4,724 | 14,563 | N/A |
| Accounts payable and accrued liabilities | 5,544 | 5,584 | 3,061 | 2,902 | 3,394 |
| Accrued Expenses | 8,823 | 6,017 | 6,217 | 3,639 | 3,189 |
| Other current liabilities | 627 | 901 | 847 | 143 | 22 |
| TOTAL | $29,597 | $32,967 | $36,423 | $31,956 | $50,181 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,545 | 8,876 | 10,000 | N/A | N/A |
| Deferred Revenues | 14,603 | 19,465 | 21,574 | 10,709 | 43,576 |
| Other Non-Current Liabilities | 481 | 134 | 102 | 1,722 | 1,292 |
| TOTAL | $32,466 | $25,614 | $55,177 | $15,309 | $7,492 |
| Total Liabilities | $62,063 | $58,581 | $91,600 | $47,265 | $57,673 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,589 | 2,310 | 2,293 | N/A | N/A |
| Common Shares | 46 | 23 | 23 | N/A | N/A |
| Retained earnings | -227,873 | -195,745 | -150,328 | -115,011 | -95,323 |
| Other shareholders' equity | 129 | 165 | -47 | 102,297 | 102,298 |
| TOTAL | $332,048 | $97,789 | $131,539 | $-6,496 | $11,621 |
| Total Liabilities And Equity | $394,111 | $156,370 | $223,139 | $40,769 | $69,294 |